Clinical Trial Update: A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A multicenter Phase IIb trial is evaluating the efficacy and safety of B1962 Injection for advanced colorectal cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• B1962 Injection (B1962)

Snippet

Sponsor: Tasly Biopharmaceuticals Co., Ltd. | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING